Molecular imaging of activated platelets via antibody-targeted ultra-small iron oxide nanoparticles displaying unique dual MRI contrast-Reference-Cited by-同舟云学术

Molecular imaging of activated platelets via antibody-targeted ultra-small iron oxide nanoparticles displaying unique dual MRI contrast

Published:2017-07 Issue: Volume:134 Page:31-42
ISSN:0142-9612
Container-title:Biomaterials
language:en
Short-container-title:Biomaterials

Author:

Ta Hang T.,Li Zhen,Hagemeyer Christoph E.,Cowin Gary,Zhang Shaohua,Palasubramaniam Jathushan,Alt Karen,Wang Xiaowei,Peter Karlheinz,Whittaker Andrew K.

Funder

National Health and Medical Research Council

University of Queensland

Australian Research Council

National Heart Foundation

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Mechanics of Materials,Biomaterials,Biophysics,Ceramics and Composites,Bioengineering

Reference64 articles.

1. Heart disease and stroke statistics – 2015 update;Mozaffarian;Circulation,2015

2. Targeted nanoparticle for cardiovascular molecular imaging;Strijkers;Curr. Radiol. Rep.,2013

3. Inflammation, atherosclerosis, and coronary artery disease;Hansson;N. Engl. J. Med.,2005

4. Relationship of thrombus healing to underlying plaque morphology in sudden coronary death;Kramer;J. Am. Coll. Cardiol.,2010

5. Molecular MRI of thrombosis;Ciesienski;Curr. Cardiovasc Imaging Rep.,2010

Cited by 86 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Magnetically Actuated Nanomaterials in Biomedical Applications;Advanced NanoBiomed Research;2024-07-17

2. Nanotechnology: The Future for Diagnostic and Therapeutic Intervention in Cardiovascular Diseases is Here;Cardiology in Review;2024-05-30

3. Iron oxide nanoparticles for treatment and diagnosis of chronic inflammatory diseases: A systematic review;WIREs Nanomedicine and Nanobiotechnology;2024-05

4. Engineering Nanoplatforms for Theranostics of Atherosclerotic Plaques;Advanced Healthcare Materials;2024-04-12

5. Evaluating thrombosis risk and patient-specific treatment strategy using an atherothrombosis-on-chip model;Lab on a Chip;2024